Home > Healthcare > Medical Devices > Therapeutic Devices > Transcatheter Heart Valve Replacement Market

Transcatheter Heart Valve Replacement Market Share

  • Report ID: GMI3170
  • Published Date: Jan 2021
  • Report Format: PDF

Transcatheter Heart Valve Replacement Market Share

Some of the major players operating in the transcatheter heart valve replacement industry include

  • 4C Medical Technologies
  • Abbott
  • Boston Scientific
  • Edwards Lifesciences
  • HighLife Medical
  • JC Medical
  • LivaNova
  • Medtronic plc
  • Neovasc

These major market players are engaged in undertaking several strategic mergers, acquisitions, collaborations and partnerships in order to maintain a competitive edge over their peers. These players are also engaged in making investments that enables these players in capturing maximum revenue share.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The market size for transcatheter heart valve replacement was over USD 6.2 billion in 2019 and will expand at 17.6% CAGR up to 2026 with increasing demand for less invasive surgeries.

The market share of transcatheter mitral valve repair & replacement segment will record 23.6% CAGR between 2020-2026 as mitral regurgitation is among the most common abnormalities in geriatric population.

According to the analysts at GMI, the transapical approach segment is projected to witness around 18% CAGR through 2026.

Hospitals contributed over USD 3.65 billion to industry in 2019 with the increased availability of reimbursement schemes for procedures performed at these facilities.

In North America, the U.S. held around 88% of the market share during 2019 owing to a rising prevalence of heart valve disorders in the country.

Transcatheter Heart Valve Replacement Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2019
  • Companies covered: 11
  • Tables & Figures: 448
  • Countries covered: 19
  • Pages: 250
 Download Free Sample